Studying the complex molecular mechanisms involved in traumatic brain injury (TBI) is
crucial for developing new therapies for TBI. Current treatments for TBI are primarily focused …

Any type of brain injury that transpires post-birth is referred to as Acquired Brain Injury (ABI).
In general, ABI does not result from congenital disorders, degenerative diseases, or by brain …

Traumatic brain injury (TBI) remains one of the leading causes of mortality and morbidity
worldwide, yet despite extensive efforts to develop neuroprotective therapies for this …

Traumatic brain injury (TBI) is the leading cause of death in young adults and children. The
treatment of TBI in the acute phase has improved substantially; however, the prevention and …

Traumatic brain injury (TBI) causes secondary biochemical changes that contribute to
subsequent tissue damage and associated neuronal cell death. Neuroprotective treatments …

Astrogliosis, a cellular reaction with specific structural and functional characteristics,
represents a remarkably homotypic response of astrocytes to all kinds of central nervous …

Cell death after traumatic brain injury (TBI) is a major cause of neurological deficits and
mortality. Understanding the mechanisms of delayed post-traumatic cell loss may lead to …

Traumatic brain injury (TBI) induces secondary biochemical changes that contribute to
delayed neuroinflammation, neuronal cell death, and neurological dysfunction. Attenuating …

The long-term consequences of traumatic brain injury (TBI), specifically the detrimental
effects of inflammation on the neurogenic niches, are not very well understood. In the …

Over the last few years, thousands of soldiers and an even greater number of civilians have
suffered traumatic injuries due to blast exposure, largely attributed to improvised explosive …